Authors:
NEMUNAITIS J
POOLE C
PRIMROSE J
ROSEMURGY A
MALFETANO J
BROWN P
BERRINGTON A
CORNISH A
LYNCH K
RASMUSSEN H
KERR D
COX D
MILLAR A
Citation: J. Nemunaitis et al., COMBINED ANALYSIS OF STUDIES OF THE EFFECTS OF THE MATRIX METALLOPROTEINASE INHIBITOR MARIMASTAT ON SERUM TUMOR-MARKERS IN ADVANCED CANCER - SELECTION OF A BIOLOGICALLY-ACTIVE AND TOLERABLE DOSE FOR LONGER-TERM STUDIES, Clinical cancer research, 4(5), 1998, pp. 1101-1109
Authors:
NEMUNAITIS J
POOLE C
PRIMROSE J
ROSEMURGY A
MALFETANO J
BROWN P
BERRINGTON A
CORNISH A
LYNCH K
RASMUSSEN H
KERR D
COX D
MILLAR A
Citation: J. Nemunaitis et al., COMBINED ANALYSIS OF STUDIES OF THE EFFECTS OF THE MATRIX METALLOPROTEINASE INHIBITOR MARIMASTAT ON SERUM TUMOR-MARKERS IN ADVANCED CANCER - SELECTION OF A BIOLOGICALLY-ACTIVE AND TOLERABLE DOSE FOR LONGER-TERM STUDIES, Clinical cancer research, 4(5), 1998, pp. 1101-1109
Authors:
CARLSON JA
LAMB P
MALFETANO J
AMBROS RA
MIHM MC
Citation: Ja. Carlson et al., CLINICOPATHOLOGICAL COMPARISON OF VULVAR AND EXTRAGENITAL LICHEN-SCLEROSUS - HISTOLOGIC VARIANTS, EVOLVING LESIONS, AND ETIOLOGY OF 141 CASES, Modern pathology, 11(9), 1998, pp. 844-854
Authors:
CARLSON JA
AMBROS R
MALFETANO J
ROSS J
GRABOWSKI R
LAMB P
FIGGE H
MIHM MC
Citation: Ja. Carlson et al., VULVAR LICHEN-SCLEROSUS AND SQUAMOUS-CELL CARCINOMA - A COHORT, CASE-CONTROL, AND INVESTIGATIONAL STUDY WITH HISTORICAL-PERSPECTIVE - IMPLICATIONS FOR CHRONIC INFLAMMATION AND SCLEROSIS IN THE DEVELOPMENT OF NEOPLASIA, Human pathology, 29(9), 1998, pp. 932-948
Citation: Kj. Murphy et al., ETIDRONATE THERAPY DECREASES THE SENSITIVITY OF BONE SCANNING WITH METHYLENE DIPHOSPHONATE LABELED WITH TC-99M, Canadian Association of Radiologists journal, 48(3), 1997, pp. 199-202
Authors:
HUININK WTB
GORE M
CARMICHAEL J
GORDON A
MALFETANO J
HUDSON I
BROOM C
SCARABELLI C
DAVIDSON N
SPANCZYNSKI M
BOLIS G
MALMSTROM H
COLEMAN R
FIELDS SC
HERON JF
Citation: Wtb. Huinink et al., TOPOTECAN VERSUS PACLITAXEL FOR THE TREATMENT OF RECURRENT EPITHELIALOVARIAN-CANCER, Journal of clinical oncology, 15(6), 1997, pp. 2183-2193
Authors:
HUININK WTB
CARMICHAEL J
ARMSTRONG D
GORDON A
MALFETANO J
Citation: Wtb. Huinink et al., EFFICACY AND SAFETY OF TOPOTECAN IN THE TREATMENT OF ADVANCED OVARIAN-CARCINOMA, Seminars in oncology, 24(1), 1997, pp. 19-25
Authors:
CARLSON JA
AMBROS R
MALFETANO J
ROSS J
GRABOWSKI R
LAMB P
FIGGE H
MIHM MC
Citation: Ja. Carlson et al., VULVAR LICHEN-SCLEROSUS SHOWS PREMALIGNANT CHANGES NOT APPARENT BY LIGHT-MICROSCOPY, Laboratory investigation, 76(1), 1997, pp. 562-562
Authors:
AMBROS RA
SHEEHAN CE
KALLAKURY BVS
ROSS JS
MALFETANO J
PAUNOVICH E
FIGGE J
Citation: Ra. Ambros et al., MDM2 AND P53 PROTEIN EXPRESSION IN THE HISTOLOGIC SUBTYPES OF ENDOMETRIAL CARCINOMA, Modern pathology, 9(12), 1996, pp. 1165-1169
Authors:
AMBROS RA
ROSS JS
KALLAKURY BVS
MALFETANO J
KIM YR
HWANG J
BREESE K
FIGGE J
Citation: Ra. Ambros et al., P53 GENE STATUS IN ENDOMETRIAL CARCINOMAS SHOWING DIFFUSE POSITIVITY FOR P53 PROTEIN BY IMMUNOHISTOCHEMICAL ANALYSIS, Modern pathology, 8(4), 1995, pp. 441-445
Authors:
NAZEER T
BALLOUK F
MALFETANO J
FIGGE H
AMBROS R
Citation: T. Nazeer et al., MULTIVARIATE SURVIVAL ANALYSIS OF CLINICOPATHOLOGICAL FEATURES IN SURGICAL STAGE-I ENDOMETRIOID CARCINOMA INCLUDING ANALYSIS OF HER-2 NEU EXPRESSION/, Laboratory investigation, 70(1), 1994, pp. 10000093-10000093
Authors:
AMBROS RA
VIGNA PA
FIGGE J
KALLAKURY BVS
MASTRANGELO A
EASTMAN AY
MALFETANO J
FIGGE HL
ROSS JS
Citation: Ra. Ambros et al., OBSERVATIONS ON TUMOR AND METASTATIC SUPPRESSOR GENE STATUS IN ENDOMETRIAL CARCINOMA WITH PARTICULAR EMPHASIS ON P53, Cancer, 73(6), 1994, pp. 1686-1692
Authors:
MALFETANO J
KEYS H
KREDENTSER D
CUNNINGHAM M
KOTLOVE D
WEISS L
Citation: J. Malfetano et al., WEEKLY CISPLATIN AND RADICAL RADIATION-THERAPY FOR ADVANCED, RECURRENT, AND POOR-PROGNOSIS CERVICAL-CARCINOMA, Cancer, 71(11), 1993, pp. 3703-3706